Pharmaceuticals

Global Vasomotor Symptoms of Menopause Treatment Market Research Report 2021 - Impact of COVID-19 on the Market

SKU ID :Maia-19003275 | Published Date: 26-Aug-2021 | No. of pages: 126

Description

Menopause is known as the end of the female reproductive period and usually occurs in nearly 85% of women at the age of 40. Menopause leads to a decrease in estrogen and an increase in gonadotropins, leading to a cessation of the menstrual cycle and menstrual flow. These physiological changes lead to vasomotor symptoms. Vasomotor symptoms are a transition between the two phases of menopause and menopause.
The Vasomotor Symptoms of Menopause Treatment market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Vasomotor Symptoms of Menopause Treatment market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Vasomotor Symptoms of Menopause Treatment Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Vasomotor Symptoms of Menopause Treatment market are:
Pherin Pharmaceuticals, Inc.
Mithra Pharmaceuticals S.A.
Radius Health, Inc.
MenoGeniX, Inc.
Pivot Pharmaceuticals Inc
Amgen Inc.
EndoCeutics, Inc.
TherapeuticsMD, Inc.
Euroscreen S.A.

Most important types of Vasomotor Symptoms of Menopause Treatment products covered in this report are:
Estetrol
Fezolinetant
FP-101
HBN-2
Others

Most widely used downstream fields of Vasomotor Symptoms of Menopause Treatment market covered in this report are:
Hospital
Homecare
Clinic

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.